Mobile Learning Impact on Blood Glucose Control among People at Risk of Type 2 Diabetes Referring to Ahvaz Diabetes Consultation Center

Aim: Type 2 diabetes is a preventable disease and can be prevented in people at risk by doing appropriate interventions and selecting new educational practices. Mobile learning is one of the modern educational techniques used for providing opportunities for the transmission of information, as well as strengthening and improving lifelong learning for learners. We aimed to investigate mobile learning impact on blood glucose control in people with type 2 diabetes referred to Ahvaz Diabetes Consultation Center. Methods: This semi-experimental study was conducted on 60 samples selected by the random stratified sampling method. The subjects were divided into two groups: experimental group and control group. In this study, data were measured using the fasting blood sugar, DPS software and the demographic questionnaire. Before the start of the intervention, demographic profile and fasting blood sugar level were recorded in the relevant form. A designed software program was loaded on the cell phones of the experimental group. After three weeks, the blood samples were taken. Data were analyzed using the descriptive-analytical statistics tests. The significance level was considered to be less than 0.05. Findings: The findings showed that the positive effect of implementation the training program by mobile learning method was statistically significant in the control of blood sugar in the experimental group (P<0.001). Conclusion: Mobile learning is one of the modern educational practices that can be used to control blood glucose in people at a higher risk of type 2 diabetes. The use of educational technology can be considered as a good way to help the improvement of the health outcomes and behavior of people at risk for diabetes.

Mobile Learning Impact on Blood Glucose Control among People at Risk of Type 2 Diabetes Referring to Ahvaz Diabetes Consultation Center Keywords:

Mobile learning , Type 2 diabetes , Ahvaz